Verified developments translated with care
Consortium announcements, evidence reviews and Asia-Pacific field notes.
Dry silk-fibroin carriers show different EV-release profiles across 14 days
A study compares carrier structures and in vitro cell responses, with conclusions limited to its own EV and material combination.
Read full article →
Different training states, different molecular features in older muscle
A human multiomics study connects muscle-aging patterns with fitness, without demonstrating a percentage reversal of overall aging.
Read full article →
Could EVs affect skin epigenetic age? A review proposes a research hypothesis
A conceptual review connects extracellular vesicles and age clocks, while acknowledging limited direct evidence in skin.
Read full article →
cGAS loss worsens frailty in mice: an anti-inflammatory target has more complex functions
Nuclear functions of cGAS complicate how gene-knockout results should be interpreted for drug development.
Read full article →
Observing frailty through the skin microbiome: JAX outlines a research window
Skin offers repeatable sampling opportunities, but links with frailty still need longitudinal and causal evidence.
Read full article →
Why kidney repair can change course: a review focuses on continuing cellular dialogue
A mechanistic review places interactions among tubular epithelial, immune and fibroblast cells at the center of repair outcomes.
Read full article →Interpretation of the World's First Official Compliance Standard for Longevity Medicine Clinics: An Authoritative Guide to the Department of Health – Abu Dhabi (DoH) Healthy Longevity Medicine Clinic Standard, with Asia-Pacific Practice Recommendations
The TASCAP Academic Committee interprets the world's first official standard for longevity medicine clinics, issued by Abu Dhabi's Department of Health in October 2024 and effective April 2025, covering MDT qualifications, the three-tier classification of diagnostics and interventions, and copyright attribution.
Read full article →Interpretation of China's Group Standard Clinical Testing Guidelines for Anti-Aging Medicine: An Evidence-Based Tiered Framework Based on T/FDSA and Biological Age Assessment
An interpretation of the Clinical Testing Guidelines for Anti-Aging Medicine, drafted by Beijing Geriatric Hospital and governed by T/FDSA, covering the AgeDev age-deviation formula, a three-tier (strong / conditional / emerging) testing map, and quality control specifications.
Read full article →Interpretation of China's Group Standard Basic Requirements for the Setup of Anti-Aging Medicine Clinics: A Clinic Development and MDT Operations Guide Based on T/FDSA 0100-2025
An interpretation of the T/FDSA 0100-2025 group standard, covering clinic positioning, facilities, the six-role MDT configuration table, and the closed-loop service workflow of assessment → intervention → monitoring → referral.
Read full article →